[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339788-105":59,"doc-detail-339788-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cervical-cancer-genetic-profile-through-circulating-tumor-dna-what-can-we-learn-from-blood","Cervical Cancer Genetic Profile through Circulating Tumor DNA - What Can We Learn from Blood?","","Cervical cancer is a major cause of gynecologic cancer mortality worldwide, driven primarily by human papillomavirus infection. Standard screening relies on cytological Pap smear testing, yet improved specificity, sensitivity, and diagnostic reliability remain necessary. This review examines blood-based liquid biopsies that isolate circulating tumor DNA (ctDNA) for screening, diagnosis, prognosis, and surveillance, emphasizing ctDNA and the added potential of HPV-ctDNA across clinical stages for patient management.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cervical-cancer-genetic-profile-through-circulating-tumor-dna-what-can-we-learn-from-blood/339788/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cervical-cancer-genetic-profile-through-circulating-tumor-dna-what-can-we-learn-from-blood/339788.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main cause of most cervical cancer cases discussed in the review?","Question",{"text":112,"@type":113},"Human papillomavirus (HPV) is identified as the main etiological agent responsible for initiation and development of most cervical cancer cases.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why is liquid biopsy based on circulating tumor DNA (ctDNA) being considered for cervical cancer?",{"text":117,"@type":113},"Liquid biopsies using blood-derived ctDNA could address gaps in screening, diagnosis, prognosis, and surveillance by improving reliability and supporting management decisions.",{"name":119,"@type":110,"acceptedAnswer":120},"How do HPV-ctDNA and ctDNA contribute at different clinical stages?",{"text":121,"@type":113},"The review highlights ctDNA’s role and the unique possibilities of additionally using HPV-ctDNA across various stages of clinical application for cervical cancer patient management.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339788,1790158831,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","biomolecules  \nReview  \nCervical Cancer Genetic Profile through Circulating Tumor DNA: What Can We Learn from Blood?  \nSevastiani Antonouli 1, Valentina Di Nisio 2,3, Nikoletta Daponte 1, Athina-Ioanna Daponte 4 and Alexandros Daponte 1, *  \nCitation: Antonouli, S.; Di Nisio, V.; Daponte, N.; Daponte, A.-I.; Daponte, A. Cervical Cancer Genetic Profile through Circulating Tumor DNA:  \nWhat Can We Learn from Blood? Biomolecules 2024, 14, 825. [https://](https://)[ ](https://)[doi.org/10.3390/biom14070825](doi.org/10.3390/biom14070825)  \nAcademic Editor: Jürg Bähler  \nReceived: 19 May 2024  \nRevised: 6 July 2024  \nAccepted: 8 July 2024  \nPublished: 10 July 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Obstetrics and Gynaecology, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41500 Larisa, Greece; [arella_935@hotmail.com](arella_935@hotmail.com) (S.A.); [nikolettadaponte@gmail.com](nikolettadaponte@gmail.com) (N.D.)  \n2 Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Huddinge, 141 86 Stockholm, Sweden; [valentina.di.nisio@ki.se](valentina.di.nisio@ki.se)  \n3 Division of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Huddinge, 171 77 Stockholm, Sweden  \n4 Second Department of Dermatology-Venereology, Aristotle University School of Medicine,  \n54124 Thessaloniki, Greece; [atdaponte@uth.gr](atdaponte@uth.gr)  \n* Correspondence: [daponte@uth.gr](daponte@uth.gr)  \nAbstract: Cervical cancer (CC) is one of the deadliest gynecological cancers worldwide. Human papillomavirus is the main etiological agent responsible for the initiation and development of most CC cases. The standard method utilized for CC screening in the global population is the cytological Pap smear test. Despite its effective validity in detecting precancerous lesions and its response to layer stages of this disease, greater screening and diagnostic reliability are needed, as well as an improvement in specificity and sensitivity. In this context, the use of liquid biopsies, like blood, for the isolation of circulating tumor DNA (ctDNA) in CC screening, diagnosis, prognosis, and surveillance could fill the gaps that still exist. In the present review, we aim to study the literature in order to collect knowledge on blood-based liquid biopsy based on descriptions of its precious molecular content and its utilization as a potential tool for CC patients’ management. We will mainly focus on the important role of the novel ctDNA and the unique possibilities to additionally use HPV-ctDNA in CC at various stages of clinical application.  \nKeywords: cervical cancer; HPV; liquid biopsy; ctDNA  \n1. Introduction  \nCervical cancer (CC) is defined as the malignant transformation of cells in the uterine cervix. The classification of the World Health Organization includes the premalignant lesions as cervical intraepithelial neoplasia (CIN), and divides histological epithelial tumors into squamous cell carcinoma, glandular, mesenchymal, mixed epithelial and mesenchymal, melanocytic, miscellaneous, lymphoid and hematopoietic, and secondary tumors [1,2] . The oncogenesis of this type of gynecological cancer is mostly correlated with infection from human papillomavirus (HPV), with at least 80% of cervical adenocarcinoma associated with HPV [3], alongside smoking, early sexual initiation, multiple sexual partners, and long-term oral contraceptive consumption [4] . HPV is an infectious carcinogenic agent that invadesthe epithelium of the cervix, oropharynx, and anus, integrating its DNA with the host cells and triggering the tumorigenic onse","cbCaik46iIaFatVk","https://ap.wps.com/l/cbCaik46iIaFatVk","pdf",1164416,14,"English","# Introduction\n## Etiology and screening background\n## Staging, prognosis, and current follow-up approaches\n# Liquid biopsy and ctDNA in cervical cancer\n## ctDNA potential across clinical applications\n## HPV-ctDNA use at different stages","[{\"question\":\"What is the main cause of most cervical cancer cases discussed in the review?\",\"answer\":\"Human papillomavirus (HPV) is identified as the main etiological agent responsible for initiation and development of most cervical cancer cases.\"},{\"question\":\"Why is liquid biopsy based on circulating tumor DNA (ctDNA) being considered for cervical cancer?\",\"answer\":\"Liquid biopsies using blood-derived ctDNA could address gaps in screening, diagnosis, prognosis, and surveillance by improving reliability and supporting management decisions.\"},{\"question\":\"How do HPV-ctDNA and ctDNA contribute at different clinical stages?\",\"answer\":\"The review highlights ctDNA’s role and the unique possibilities of additionally using HPV-ctDNA across various stages of clinical application for cervical cancer patient management.\"}]","Cervical Cancer Genetic Profile through Circulating Tumor DNA - What Can We Learn from Blood? | PDF",1790032196,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b915dc6e829fcd81877045a73ad5ee2.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a73debcdc43fe91cfe95f11518ebab64.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5d9260c254a891698c48ca820dcee13.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4609da11db4f589c2d9318ecc2d17d23.webp",980,1385]